FreeTender
Accepting bidsitbCzechia

Czechia – Immunosuppressive agents – Selektivní imunosupresiva - Ravulizumab III.

Issued by Institut klinické a experimentální medicíny · via TED — Tenders Electronic Daily (EU)

Verify & apply on the official portal →
Published
7 Oct 2026
Closes
11 Nov 2026, 23:59 UTC
Value
CZK 352,260,000
Reference
690837-2026
Location
Czechia
Sector
Healthcare & Pharma
Type
goods

At a glance

Institut klinické a experimentální medicíny in Czechia has published an invitation to bid in healthcare & pharma: “Czechia – Immunosuppressive agents – Selektivní imunosupresiva - Ravulizumab III.”. Submissions close on 11 November 2026, 36 days from today. The stated value is CZK 352,260,000. Quote reference 690837-2026 in any correspondence with the buyer. One document is attached to this notice. FreeTender has recorded 40 notices from this buyer since 2026, 25 of them currently open. There are 254 open healthcare & pharma notices in Czechia on FreeTender. Bids are submitted to the buyer through TED — Tenders Electronic Daily (EU), not through FreeTender.

Details

Předmětem veřejné zakázky jsou dodávky léčivých přípravků pro parenterální podání s obsahem účinné látky ravulizumab (ATC L04AJ02) pro léčbu pacientů ve schválených indikacích dle SPC platného ke dni podání nabídek.

Lots Lot 1 — Selektivní imunosupresiva - Ravulizumab III. (estimated 352260000)

Buyer: Institut klinické a experimentální medicíny

Buyer country: CZE

Procedure: open

CPV code: 33652300

Full notice, tender documents and how to bid are on the official TED page (link above).

Context for bidders

We hold 40 notices from Institut klinické a experimentální medicíny, going back to August 2026 — 25 of them still open. They buy mostly in Healthcare & Pharma, Manufacturing & Supply and Energy & Power. There are 254 open Healthcare & Pharma tenders in Czechia. This one closes in 36 days.

Documents

Before you bid on this tender

A quick checklist to help you decide whether to bid and prepare a compliant submission for this healthcare & pharma opportunity. Always verify the details on the official source.

  • Confirm the exact closing date and time (and time zone) on the official portal — deadlines are strict and can be revised by a corrigendum.
  • Read the full notice and every attached document, including the scope, specifications and any bill of quantities or terms of reference.
  • Check the eligibility criteria — prior similar experience, annual turnover, certifications and registrations — and make sure you qualify before investing effort.
  • Prepare any earnest-money deposit (EMD) or bid security and the required formats early; missing or wrongly-formatted documents are a common cause of rejection.
  • Note how bids must be submitted (online or physical), in what format, and whether a digital signature or portal registration is required.
  • Watch for corrigenda and clarifications right up to the deadline — requirements and dates can change.
Common bidding mistakes to avoid →Writing a winning proposal

More Healthcare & Pharma tenders

All Healthcare & Pharma tenders →

FreeTender mirrors this notice for reference. Verify the details and bid on the official portal.

Verify & apply on the official portal →